ID: ALA5267029

Max Phase: Preclinical

Molecular Formula: C17H12ClN5O2S

Molecular Weight: 385.84

Associated Items:

Representations

Canonical SMILES:  CCOC(=O)c1nc(Sc2nnc3c(Cl)cccn23)c2ccccc2n1

Standard InChI:  InChI=1S/C17H12ClN5O2S/c1-2-25-16(24)13-19-12-8-4-3-6-10(12)15(20-13)26-17-22-21-14-11(18)7-5-9-23(14)17/h3-9H,2H2,1H3

Standard InChI Key:  BGTDNGKAHRAUAC-UHFFFAOYSA-N

Associated Targets(non-human)

Xanthomonas oryzae pv. oryzae 79 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 385.84Molecular Weight (Monoisotopic): 385.0400AlogP: 3.65#Rotatable Bonds: 4
Polar Surface Area: 82.27Molecular Species: NEUTRALHBA: 8HBD: 0
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 0.33CX LogP: 4.22CX LogD: 4.22
Aromatic Rings: 4Heavy Atoms: 26QED Weighted: 0.39Np Likeness Score: -1.93

References

1. Aggarwal R, Sumran G..  (2020)  An insight on medicinal attributes of 1,2,4-triazoles.,  205  [PMID:32771798] [10.1016/j.ejmech.2020.112652]

Source